Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205050
Company: MYLAN

Products on ANDA 205050

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TRAVOPROST	TRAVOPROST	0.004%	SOLUTION/DROPS;OPHTHALMIC	Prescription	AT	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 205050

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/07/2017	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/29/2024	SUPPL-4	Labeling-Package Insert		Label is not available on this site.
03/29/2024	SUPPL-3	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 205050

TRAVOPROST

SOLUTION/DROPS;OPHTHALMIC; 0.004%
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
TRAVATAN Z	TRAVOPROST	0.004%	SOLUTION/DROPS;OPHTHALMIC	Prescription	Yes	AT	021994	SANDOZ
TRAVOPROST	TRAVOPROST	0.004%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	203431	APOTEX
TRAVOPROST	TRAVOPROST	0.004%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	203767	MICRO LABS
TRAVOPROST	TRAVOPROST	0.004%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	205050	MYLAN